| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |